Association between sickle cell anemia and alpha thalassemia reveals a high prevalence of the alpha(3.7) triplication in congolese patients than in worldwide series.
Mikobi, Tite Minga; Lukusa, Prosper Tshilobo; Aloni, Michel Ntetaniet al.
2018 • In Journal of Clinical Laboratory Analysis, 32 (1)
Adolescent; Adult; Anemia, Sickle Cell/complications/epidemiology/genetics; Child; Cross-Sectional Studies; Democratic Republic of the Congo/epidemiology; Female; Gene Duplication/genetics; Humans; Male; Prevalence; Young Adult; alpha-Thalassemia/complications/epidemiology/genetics; Kinshasa; alpha thalassemia; multiplex ligation dependent probe amplification; sickle cell anemia; the Democratic Republic of Congo, Africa; alpha3.7 triplication
Abstract :
[en] BACKGROUND: Information about the association with alpha thalassemia in sickle cell patients is unknown in the Democratic Republic of Congo. There is very little data on the alpha thalassemia in patients suffering from sickle cell anemia in Central Africa, and their consequences on the clinical expression of the disease. METHODS: A cross-sectional study was conducted in 106 sickle cell patients living in the country's capital Kinshasa. The diagnosis of sickle cell anemia was confirmed with a molecular test using PCR-RFLP (restriction fragment length polymorphism) technique. The diagnosis of thalassemia was performed by the technique of multiplex ligation dependent probe amplification. RESULTS: The mean age of our patients was 22.4+/-13.6 years. The alpha(3.7) heterozygous deletion, the alpha(3.7) homozygous deletion and the alpha(3.7) triplication were respectively encountered in 23.6%, 25.5% , and 11.3% of patients. Patients with normal alphaalpha/alphaalpha genotype represented 39.6% of the study population. The average of severe vaso-occlusive crises, the rates of blood transfusions per year, the rate of osteonecrosis, cholelithiasis and leg ulcers were significantly lower in the group of patients with alpha(3.7) homozygous deletion and alpha(3.7) triplication. CONCLUSION: The prevalence of alpha(3.7) triplication was higher in sickle cell patients in the Democratic Republic of Congo than in worldwide series. The alpha(3.7) triplication and alpha(3.7) homozygous deletion were associated with less severe forms of the Sickle cell anemia in Congolese patients. These results showed the need to investigate systematically the alpha-globin gene mutations in sickle cell population in Central Africa.
Association between sickle cell anemia and alpha thalassemia reveals a high prevalence of the alpha(3.7) triplication in congolese patients than in worldwide series.
Publication date :
2018
Journal title :
Journal of Clinical Laboratory Analysis
ISSN :
0887-8013
eISSN :
1098-2825
Publisher :
John Wiley & Sons, Hoboken, United States - New York
Thein SL. Genetic modifiers of the beta-haemoglobinopathies. Br J Haematol. 2008;141:357-366.
Sebastiani P, Solovieff N, Hartley SW, et al. Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study. Am J Hematol. 2010;85:29-35.
Akinsheye I, Alsultan A, Solovieff N, et al. Fetal hemoglobin in sickle cell anemia. Blood. 2011;118:19-27.
Steinberg MH, Sebastiani P. Genetic modifiers of sickle cell disease. Am J Hematol. 2012;87:795-803.
Thein SL. Genetic association studies in β-hemoglobinopathies. Hematology Am Soc Hematol Educ Program. 2013;2013:354-361.
Hedrick PW. Selection and mutation for α Thalassemia in nonmalarial and malarial environments. Ann Hum Genet. 2011;75:468-474. doi:10.1111/j.1469-1809.2011.00653.x.
Rumaney MB, Ngo Bitoungui VJ, Vorster AA, et al. The co-Inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rates in Cameroonian patients and could improve their survival. PLoS ONE. 2014;9:e100516.
Rodgers GP, Steinberg MH. Pharmacologic treatment of sickle cell disease and thalassemia: the augmentation of fetal hemoglobin. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, eds. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management, 1st edn. Cambridge, United Kingdom: Cambridge University Press; 2001:1028-1051.
Suchdev PS, Ruth LJ, Earley M, et al. The burden and consequences of inherited blood disorders among young children in western Kenya. Matern Child Nutr. 2014;10:135-144.
Veenemans J, Andang'o PE, Mbugi EV, et al. Alpha+-thalassemia protects against anemia associated with asymptomatic malaria: evidence from community-based surveys in Tanzania and Kenya. J Infect Dis. 2008;198:401-8.
Bernini LF, Harteveld CL. Alpha-thalassaemia, In: Rodgers GP, ed. Bailliere's Clinical Haematology International Practice and Research: Sickle Cell Disease and Thalassaemia, Vol. 11. London: Bailliere Tindall; 1998:53-90.
Piel FB, Hay SI, Gupta S, et al. Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10:e1001484.
Tshilolo L, Aissi LM, Lukusa D, et al. Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns. J Clin Pathol. 2009;62:35-38.
Agasa B, Bosunga K, Opara A, et al. Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: what impact on transfusion policy? Transfus Med. 2010;20:62-65.
Tshilolo L, Summa V, Gregorj C, et al. Foetal haemoglobin, erythrocytes containing foetal haemoglobin, and hematological features in congolese patients with sickle cell anaemia. Anemia. 2012;2012:105349.
Ballas SK. More definitions in sickle cell disease: steady state v base line data. Am J Hematol. 2012;87:338.
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
Mouélé R, Pambou O, Feingold J, et al. Alpha-thalassemia in Bantu population from Congo-Brazzaville: its interaction with sickle cell anemia. Hum Hered. 2000;50:118-125.
Lubega I, Ndugwa CM, Mworozi EA, et al. Alpha thalassemia among sickle cell anaemia patients in Kampala. Uganda. Afr Health Sci. 2015;15:682-689. doi:10.4314/ahs.v15i2.48.
Cox SE, Makani J, Soka D, et al. Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania. Br J Haematol. 2014;165:699-706. doi:10.1111/bjh.12791.
Pandey S, Pandey S, Mishra RM, et al. Genotypic influence of α-deletions on the phenotype of Indian sickle cell anemia patients. Korean J Hematol. 2011;46:192-195.
Nouraie M, Lee JS, Zhang Y, et al. Walk-PHASST Investigators and Patients. The relationship between the serverity of hemolysis clinical manifestation and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica. 2013;98:464-472.
Wali YA, Al-Lamki Z, Hussein SS, et al. Splenic function in Omani children with sickle cell disease: correlation with severity index, hemoglobin phenotype, irion status, and alpha-thalassemia trait. Pediatr Hematol Oncol. 2002;19:491-500.
Kumar R, Panigrahi I, Dalal A, et al. Sickle cell anemia–molecular diagnosis and prenatal counseling: SGPGI experience. Indian J Pediatr. 2012;79:68-74. doi:10.1007/s12098-011-0510-1.
Ataulfo González F, Blázquez C, Ropero PGrupo de Eritropatología, et al. Association of hemoglobinopathy and alpha thalassemia. Study of 45 patients. Med Clin (Barc). 2005;124:726-9.
Kéclard L, Ollendorf V, Berchel C, et al. Beta S haplotypes, alpha-globin gene status, and hematological data of sickle cell disease patients in Guadeloupe (F.W.I.). Hemoglobin. 1996;20:63-74.
Goossens M, Dozy AM, Embury SH, et al. Triplicated α-globin loci in humans. Proc Natl Acad Sci USA. 1980;77:518-521.
El-Hazmi MAF. Clinical manifestation and laboratory findings of sickle cell anaemia in association with alpha-thalassemia in Saudi Arabia. Acta Haematol. 1985;74:155-160.
Conran N, Costa FF. Hemoglobin disorders and endothelial cell interactions. Clin Biochem. 2009;42:1824-1838.
Hebbel RP, Schwartz RS, Mohandas N. The adhesive sickle erythrocyte: cause and consequence of abnormal interactions with endothelium, monocytes/macrophages and model membranes. Clin. Haematol. 1985;191:141-161.
Meier ER, Byrnes C, Weissman M, et al. Absolute reticulocyte count acts as a surrogate for fetal hemoglobin in infants and children with sickle cell anemia. PLoS ONE. 2015;10:e0136672. doi:10.1371/journal.pone.0136672.
Hebbel RP. Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies. N Engl J Med. 2000;342:1910-1912.
Morris CR. Vascular risk assessment in patients with sickle cell disease. Haematologica. 2011;96:1-5.
Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest. 2007;117:850-858.
Mikobi TM, Lukusa Tshilobo P, Aloni MN, et al. Correlation between the lactate dehydrogenase levels with laboratory variables in the clinical severity of sickle cell anemia in congolese patients. PLoS ONE. 2015;10:e0123568. doi:10.1371/journal.pone.0123568.
Longo-Mbenza B, Ngiyulu R, Kizunda P, et al. Gallbladder disease in young Congolese with sickle cell anemia: an ultrasound survey. J Trop Pediatr. 2004;50:73-77.
Steinberg MH. Genetic etiologies for phenotypic diversity in sickle cell anemia. ScientificWorldJournal. 2009;9:46-67.
Ballas SK, Talacki CA, Rao VM, et al. The prevalence of avascular necrosis in sickle cell anemia: correlation with alpha-thalassemia. Hemoglobin. 1989;13:649-655.
Adekile AD, Gupta R, Yacoub F, et al. Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of alpha-thalassemia trait. Acta Haematol. 2001;105:27-31.
Milner PF, Kraus AP, Sebes JI, et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med. 1991;325:1476-1481.
Pandey SK, Pandey S, Ranjan R, et al. Phenotypic effect of α-globin gene numbers on Indian sickle β-thalassemia patients. J Clin Lab Anal. 2014;28:110-113. doi:10.1002/jcla.21652.